UNSPSC 51162319: Acetaminophen/diphenhydramine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162319 Acetaminophen/diphenhydramine/phenylephrine is a Commodity code. State and local governments use this code to procure combination pain-relief and decongestant products, though the recent opportunities block shows purchasing activity that diverges significantly from the code's nominal scope. The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) tagged under this code actually solicits naloxone and safe drug deactivation systems for community health initiatives—products wholly outside the acetaminophen/diphenhydramine/phenylephrine formulation. The MMCAP RFP (S1070000015802, due March 26, 2026), administered by the Minnesota Department of Administration's Office of State Procurement for multi-state cooperative purchasing, does encompass generic pharmaceuticals and OTC products but does not isolate acetaminophen/diphenhydramine/phenylephrine as a line item. The code shows limited recent activity specifically aligned with its stated product scope.

The geographic footprint visible in the source spans Florida (Seminole County) and Minnesota (MMCAP, which extends to participating jurisdictions including Oregon), but the mismatch between the code's nominal definition and actual recent solicitations indicates this code may not be a reliable predictor of current acetaminophen/diphenhydramine/phenylephrine procurement volume. The MMCAP RFP represents cooperative purchasing across multiple state and local facilities and requires vendors to establish relationships with three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), maintain cGMP and DSCSA compliance, carry $5 million commercial general liability insurance, and accept a 3 percent administrative fee, with awards effective July 1, 2026. The Seminole County opportunity, while mislabeled under this code, demonstrates community health procurement through county health departments but addresses opioid response rather than combination analgesics.